miR-211 suppresses hepatocellular carcinoma by downregulating SATB2.

Jiang G, Cui Y, Yu X, Wu Z, Ding G, Cao L

DOI: 10.18632/oncotarget.3265
Published: 2015 Apr 20
Container: Oncotarget
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.18632/oncotarget.3265,
  title = {miR-211 suppresses hepatocellular carcinoma by downregulating SATB2.},
  author = {Jiang G and Cui Y and Yu X and Wu Z and Ding G and Cao L},
  year = {2015},
  journal = {Oncotarget},
  doi = {10.18632/oncotarget.3265},
  url = {https://doi.org/10.18632/oncotarget.3265}
}

RIS

TY  - JOUR
TI  - miR-211 suppresses hepatocellular carcinoma by downregulating SATB2.
AU  - Jiang G
AU  - Cui Y
AU  - Yu X
AU  - Wu Z
AU  - Ding G
AU  - Cao L
PY  - 2015
JO  - Oncotarget
DO  - 10.18632/oncotarget.3265
UR  - https://doi.org/10.18632/oncotarget.3265
ER  -

APA

G, J., Y, C., X, Y., Z, W., G, D., & L, C. (2015). miR-211 suppresses hepatocellular carcinoma by downregulating SATB2.. Oncotarget. https://doi.org/10.18632/oncotarget.3265

Source records

pubmed · retrieved 2026-09-24T20:37:26.305Z